James Manuso - Nov 18, 2021 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
Director
Signature
/s/ Jeffrey Kuras, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Nov 18, 2021
Transactions value $
$7,000
Form type
4
Date filed
11/22/2021, 03:01 PM
Previous filing
Jun 9, 2021
Next filing
May 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Purchase $7K +2K +13.73% $3.50 16.6K Nov 18, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $3.4966 to $3.4998. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.